Last: | $173.62 |
---|---|
Change Percent: | -0.61% |
Open: | $173.56 |
Close: | $173.62 |
High: | $173.79 |
Low: | $171.29 |
Volume: | 858,130 |
Last Trade Date Time: | 07/09/2025 03:41:41 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$173.62 | $173.56 | $173.62 | $173.79 | $171.29 | 858,130 | 07-09-2025 |
$172.5 | $173.21 | $172.5 | $174.48 | $172.13 | 1,080,477 | 07-08-2025 |
$173.97 | $175.96 | $173.97 | $176.11 | $173.08 | 839,409 | 07-07-2025 |
$176.92 | $176.14 | $176.92 | $176.92 | $175.7 | 436,517 | 07-04-2025 |
$176.12 | $175.3435 | $176.12 | $176.12 | $174.9055 | 436,517 | 07-03-2025 |
$176.6 | $179.12 | $176.6 | $179.12 | $174.635 | 895,745 | 07-02-2025 |
$179.33 | $179.36 | $179.33 | $181.15 | $178.07 | 850,360 | 07-01-2025 |
$179.63 | $177.86 | $179.63 | $179.755 | $177.2125 | 819,342 | 06-30-2025 |
$177.83 | $177.15 | $177.83 | $180.24 | $176.56 | 1,205,898 | 06-27-2025 |
$177.06 | $179.53 | $177.06 | $180.09 | $175.64 | 1,040,223 | 06-26-2025 |
$178.65 | $179.32 | $178.65 | $179.32 | $177.55 | 747,546 | 06-25-2025 |
$179.9 | $179.75 | $179.9 | $180.025 | $177.32 | 713,589 | 06-24-2025 |
$179.72 | $179.38 | $179.72 | $180.32 | $178.52 | 1,201,926 | 06-23-2025 |
$179.43 | $180 | $179.43 | $181 | $178.745 | 1,016,742 | 06-20-2025 |
$179.78 | $178.78 | $179.78 | $180.83 | $177.7624 | 618,901 | 06-19-2025 |
$179.78 | $178.78 | $179.78 | $180.83 | $177.7624 | 618,901 | 06-18-2025 |
$178.95 | $181.04 | $178.95 | $182.2621 | $178.38 | 871,882 | 06-17-2025 |
$182.07 | $180.93 | $182.07 | $182.375 | $179.21 | 989,119 | 06-16-2025 |
$180.21 | $178 | $180.21 | $181.905 | $177.7102 | 1,028,465 | 06-13-2025 |
$179.04 | $177.13 | $179.04 | $179.845 | $176.28 | 743,182 | 06-12-2025 |
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
-0.61% G/L:
$173.62 Last:
858,130 Volume:
$173.56 Open:
$173.62 Close:
Quest Diagnostics Incorporated Website:
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease PR Newswire Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patien...
Quest Diagnostics Releases 2024 Corporate Responsibility Report PR Newswire SECAUCUS, N.J. , June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Rep...
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 PR Newswire SECAUCUS, N.J. , June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will rep...